Dr. Saglam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
707 E Main St
Middletown, NY 10940Phone+1 845-333-7373
Education & Training
Istanbul UniversityClass of 2017
Publications & Presentations
PubMed
- 1 citationsPhospho-Sulindac (OXT-328) Inhibits Dry Eye Disease in Rabbits: A Dose-, Formulation- and Structure-Dependent Effect.Wei Huang, Ziyi Wen, Muhammet S Saglam, Liqun Huang, Robert Honkanen
Journal of Ocular Pharmacology and Therapeutics. 2021-06-21
Journal Articles
- Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models of Its Main Clinical SubtypesWei Huang, Liqun Huang, Wenyi Li, Muhammet Sait Saglam, Konstantinos Tourmouzis, Sanford M Goldstein, Adam Master, Robert Honkanen, Basil Rigas, Journal of Ocular Pharmacology and Therapeutics, 12/29/2021
- Simplified ex-vivo drug evaluation in ocular surface cells: Culture on cellulose filters of cells obtained by impression cytologyAdam Master, Wei Huang, Liqun Huang, Wenyi Li, Muhammet Sait Saglam, Robert Honkanen, Basil Rigas, Experimental Eye Research, 11/3/2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
